# Assesment of the Metabolomic Signature in COVID-19 Patients

> **NCT04497272** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 150 (actual)

## Conditions studied

- COVID 19

## Interventions

- **OTHER:** COVID-19 patients

## Key facts

- **NCT ID:** NCT04497272
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-07
- **Primary completion:** 2021-03-01
- **Final completion:** 2022-07-31
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2022-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04497272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04497272, "Assesment of the Metabolomic Signature in COVID-19 Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04497272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*